Silke Gillessen
Papers
1
Total Citations
52
H-Index
1
About
Silke Gillessen is a leading oncologist whose research has fundamentally shaped the management of prostate cancer, particularly in the domains of advanced disease and focal therapy. Her work bridges the gap between clinical practice and evidence-based innovation, with a focus on optimizing treatment sequencing and patient stratification. Most notably, she co-authored the landmark "A Systematic Review of Focal Ablative Therapy for Clinically Localised Prostate Cancer in Comparison with Standard Management Options" (2021, 52 citations), which critically evaluated the limitations of current evidence for focal therapy and provided actionable recommendations for clinical practice and future research. This work has been instrumental in guiding urologists and oncologists toward more rigorous trial design and patient selection. Beyond this, Gillessen has been a driving force in the development of consensus guidelines for advanced prostate cancer, including the definition of castration-resistant disease and the role of novel hormonal agents. Her contributions have earned her international recognition, including leadership roles in major clinical trial groups. With a citation impact that underscores her influence, Gillessen continues to shape how clinicians approach both localized and metastatic prostate cancer, advocating for precision medicine and evidence-based decision-making.
Research Focus
Key Achievements
Top Papers
- 1